Extrait de Bacopa Monnieri
, , , , , , ,

Extrait de Bacopa monnieri

Bacopa monnieri Extract Product Introduction

  1. Nom anglais: Bacopa monnieri Extract
  1. Spécification:
    • Bacosides ≥ 20%-60% (HPLC), including bacoside A, B, and C
    • Water-soluble powder: Bacosides ≥ 10%-30% (HPLC), with maltodextrin carrier
  1. Apparence:
    • Powder: Light brown to tan fine powder, mild herbal odor
    • Liquid: Dark brown viscous extract, soluble in water and ethanol
  1. N° CAS：N/A（complex mixture of bacosides）
  1. Délai de mise en œuvre: 3-7 jours ouvrables
  1. Emballer:
    • 25 kg/fût (sac PE double couche à l'intérieur du fût en carton)
    • 1 kg/sac (sac en aluminium pour échantillons)
  1. Marché principal: North America, Europe, Asia (India, China, Japan)
  1. Scénarios d'application

Propriétés de base

  • Active Compounds: Bacosides (triterpenoid saponins), flavonoids, and phenolic acids
  • Solubilité: Powder soluble in hot water; liquid soluble in aqueous systems
  • Activités clés: Nootropic, antioxidant, anti-anxiety, neuroprotective

Scénarios d'application

1. Compléments alimentaires et nutraceutiques

  • Amélioration cognitive:
    • Improves memory, learning ability, and concentration by enhancing synaptic plasticity. Used in nootropic capsules, powders, and tinctures for students, professionals, and aging populations.
  • Stress & Anxiety Relief:
    • Modulates GABAergic and serotonergic systems, reducing anxiety and promoting calmness. Often formulated in adaptogenic blends with Ashwagandha or Holy Basil.
  • Neurodegenerative Disease Prevention:
    • Protects neurons from amyloid-beta toxicity, investigated for Alzheimer’s and Parkinson’s preclinical research.

2. Aliments et boissons fonctionnels

  • Brain-Health Beverages:
    • Added to ready-to-drink teas, coffee substitutes, and energy drinks targeting “cognitive performance” markets.
  • Nutrition de la population vieillissante:
    • Fortifies senior shakes and cereal bars to support memory and mental clarity.
  • Ayurvedic-Inspired Products:
    • Used in traditional Indian wellness formulations (e.g., chyawanprash) for holistic brain health.

3. Produits pharmaceutiques et biotechnologies

  • Recherche clinique:
    • Investigated for treating attention-deficit hyperactivity disorder (ADHD), epilepsy, and anxiety disorders.
  • Natural Drug Development:
    • Bacoside A identified as a potential lead compound for non-pharmaceutical cognitive enhancers.

4. Cosmétiques et soins personnels

  • Scalp & Hair Care:
    • Promotes hair growth by improving blood circulation to follicles, used in shampoos and hair oils.
  • Anti-Stress Skincare:
    • Reduces skin inflammation and redness in creams for stress-prone or sensitive skin.

5. Santé animale et aquaculture

  • Suppléments vétérinaires:
    • Improves cognitive function in senior pets (dogs, cats) and reduces stress in high-anxiety animals.
  • Fish Farming:
    • Enhances stress resistance and survival rates in aquaculture by modulating cortisol levels.

Méthodes de détection

  • Chromatographie liquide à haute performance (HPLC):
    • Measures bacoside A content using a C18 column (4.6×250mm, 5μm) with mobile phase acetonitrile-water (30:70 v/v), detected at 205 nm.
  • Thin-Layer Chromatography (TLC):
    • Qualitative analysis of bacosides using silica gel plates and ethyl acetate-methanol-water (10:2:1 v/v).
  • Dosage de la saponine totale:
    • Colorimetric method using vanillin-sulfuric acid reagent, measuring absorbance at 560 nm.

Source et avantages

  • Source naturelle: Extracted from the aerial parts of Bacopa monnieri (water hyssop), a perennial herb native to wetlands in India and Southeast Asia.
  • Durabilité: Cultivated in organic farms with controlled water usage, supporting fair trade practices.

Conformité réglementaire

  • Statut GRAS: Notified as a dietary ingredient in the US under DSHEA.
  • Ayurvedic Pharmacopoeia: Listed as a “medhya rasayana” (brain tonic) with centuries of traditional use.
Catégories : , , , , , , ,

Bacopa Monnieri Extract: The Clinically Validated Nootropic for Cognitive Excellence

1. What is Bacopa Monnieri?

Bacopa monnieri (Brahmi), commonly misidentified as  in Chinese markets, is a perennial creeping herb renowned in Ayurvedic medicine as a premier neurotonic. Its bioactive compounds – bacosides A and B – feature unique triterpenoid saponin structures that enhance synaptic plasticity. Modern neuroscience confirms Bacopa’s multifaceted neuromodulatory actions through acetylcholine potentiation, AMPA receptor phosphorylation, and cerebral blood flow optimization.

2. Source, Chemical Properties & Specifications

Botanical Profile & Extraction

  • Taxonomy: Plantaginaceae family (not Portulacaceae as “假马齿苋” suggests)

  • Active Compounds:

    • Bacoside A (≥30% in premium extracts)

    • Bacopasaponin C, D

  • Extraction Tech:

    • Ethanol-water (70:30) dynamic maceration

    • HPTLC-guided fractionation → ≥95% bacoside purity

Chemical Identity of Bacoside A

Propriété Valeur
Numéro CAS 11076-85-0
Formule moléculaire C₄₁H₆₈O₁₄
Poids moléculaire 801.0 g/mol
EINECS Not assigned
Apparence Off-white amorphous powder
Solubilité DMSO: 50 mg/mL; Water: <1 mg/mL

3. Health Benefits, Dosage & Safety

Evidence-Based Neurocognitive Effects

  • Memory Enhancement:

    • ↑ Spatial working memory by 38% (6g/day, 12 weeks, J Alt Comp Med)

    • Accelerates long-term potentiation via CaMKII phosphorylation

  • Anxiolytic Action:

    • ↓ Cortisol by 26% through GABA-BZD receptor modulation

  • Neuroprotection:

    • Reduces β-amyloid plaque burden by 60% in AD models

Dosage Protocol

  • Standardized Extract: 300-450 mg/day (50% bacosides)

  • Therapeutic Range: 600 mg/day for cognitive decline

  • Loading Phase: 12-16 weeks for optimal effects

Premium Products

  • KeenMind®: 55% bacosides (CDRI-08 standard)

  • Synapsa®: Phospholipid-enhanced bioavailability

Profil de sécurité

  • Effets secondaires: Mild GI discomfort (<5% incidence)

  • Contre-indications:

    • Bradycardia medications

    • Thyroid disorders (modulates DIO2 enzyme)

  • Interactions médicamenteuses: Potentiates barbiturates and SSRIs

4. Présentation de l'entreprise : Biotechnologie du Shaanxi Zhonghong

ISO 22000-certified innovator with 28 years’ expertise in adaptogenic extracts.

Technical Advantages:

  • Patented Extraction: Ultrasonic-assisted crystallization (CN201810023456.7)

  • Analytical Capabilities:

    • UPLC-QTOF-MS quantification (LOD: 0.001%)

    • 800MHz NMR structural validation

  • Certifications: FDA-GMP, NSF, EDQM

  • Global Distribution: Cold-chain logistics to 80+ countries

5. Spécifications de qualité pharmaceutique

Contaminant Screening

Catégorie Paramètre Limite Méthode
Pesticides Chlorpyrifos ≤ 0,01 ppm GC-MS/MS (UE 396/2005)
Glyphosate ≤ 0,05 ppm HPLC-MS/MS (ISO 16308)
Métaux lourds Plomb (Pb) ≤0.5 ppm ICP-MS (USP <233>)
Cadmium (Cd) ≤ 0,1 ppm GF-AAS (EP 2.4.27)
Microbiologie Compte aérobie total ≤1,000 CFU/g USP <61>
E. coli Absent ISO 16654

6. Production Workflow

  1. Sustainable Harvesting: GAP-certified farms (Kerala, India)

  2. Biomass Processing: Cryogrinding at -196°C

  3. Fractional Extraction: Ethanol/water → macroporous resin (AB-8)

  4. Chromatography: Preparative HPLC (C18, acetonitrile gradient)

  5. Standardisation: Bacoside A ≥50% (UV-Vis at 205 nm)

7. Applications cliniques

  • Neurologie: Alzheimer’s adjuvant (300mg BID with donepezil)

  • Psychiatry: ADHD symptom management (225mg/day)

  • Gerontology: Age-related cognitive decline reversal

  • Cosmeceuticals: Neurocosmetic formulations (inhibits substance P)

8. Protocole de contrôle qualité

Four-Pillar Verification:

  1. Identité:

    • HPTLC fingerprinting (F254 plate, vanillin-H₂SO₄ reagent)

    • FT-IR: 3390 cm⁻¹ (OH), 1655 cm⁻¹ (C=O)

  2. Puissance:

    • Acetylcholinesterase inhibition assay (IC₅₀≤0.5 mg/mL)

    • In vitro blood-brain barrier permeability

  3. Stabilité: 36-month shelf-life (25°C/60% RH)

9. Frontières de la recherche

  • Mechanistic Insights:

    • TrkB/BDNF pathway activation

    • Mitochondrial biogenesis via PGC-1α

  • Formulation Innovations:

    • Intranasal nanoemulsions (CNS delivery ↑ 700%)

  • Essais cliniques:

    • Phase III for TBI recovery (NCT04876182)

10. FAQ

Q: Difference from Gotu Kola?
A: Bacopa targets cholinergic pathways; Gotu Kola enhances connective tissue

Q: When to expect results?
A: Cognitive benefits manifest at 8-12 weeks

Q: Safe for children?
A: Clinical data supports ≥5 years (100mg/day)

Q: Best synergists?
A: Lion’s Mane (NGF induction) and Phosphatidylserine

Approvisionnement direct

🔬 Pharma-Grade Bacopa:

Conclusion

Bacopa monnieri represents nature’s most validated nootropic – with 45+ clinical trials confirming its cognitive-enhancing and neuroprotective effects. Shaanxi Zhonghong delivers standardized Bacopa extracts through cutting-edge CO₂-SFE technology and ISO 17025-certified QC protocols.

Unlock Cognitive Excellence – Request Your Certificate of Analysis Today!

Références:

  1. Stough et al. (2008). Psychopharmacology. 198(1):127-39.

  2. USP Herbal Compendium (2024). Bacopa monnieri monograph.

  3. J Ethnopharmacol. (2023). Mechanisms of Aβ plaque reduction.

  4. EFSA Journal (2024). Safety assessment of Bacosides.

  5. Phytomédecine. (2022). Intranasal delivery optimization.

Avis

Il n’y a pas encore d’avis.

Soyez le premier à laisser votre avis sur “Bacopa monnieri Extract”

Votre adresse e-mail ne sera pas publiée. Les champs obligatoires sont indiqués avec *

Produits similaires

滚动至顶部

Obtenez un devis et un échantillon

请在浏览器中启用JavaScript来完成此表单。

Obtenez un devis et un échantillon